Clinical
Pragya Rai, MS, Nilanjana Dwibedi, BPharm, MBA, PhD, Mazhgan Rowneki, MPH, Drew A. Helmer, MD, MS, Usha Sambamoorthi, PhD
Impact of DPP-4 Inhibitors on Joint Pain in Older Veterans with Diabetes
Jeffrey T. Guptill, MD, MA, MHS, Michael C. Runken, PharmD, Michael Eaddy, PharmD, PhD, Orsolya Lunacsek, PhD, Rupali M. Fuldeore, MS
Enhanced Understanding and Management of Rare Diseases Can Reduce Costs, Improve Clinical Outcomes
Steven R. Feldman, MD, PhD, Linda S. Cox, MD, Lindsay C. Strowd, MD, Robert A. Gerber, PharmD, MA, MBA, Steven Faulkner, PharmD, MBA, Debra Sierka, PharmD, Timothy W. Smith, BA, Joseph C. Cappelleri, PhD, Mark E. Levenberg, DO
Evolving Therapies for Atopic Dermatitis Will Create New Management Challenges
Lana T. Al-Omar, PharmD, BCPS, Sarah L. Anderson, PharmD, FCCP, BCPS, BCACP, Amber D. Cizmic, PharmD, BCACP, Tara B. Vlasimsky, PharmD, BCPS, BCACP
Arijita Deb, PhD, Nilanjana Dwibedi, BPharm, MBA, PhD, Traci LeMasters, PhD, Jo Ann Hornsby, MD, Wenhui Wei, PhD, Usha Sambamoorthi, PhD
Comorbidities in Rheumatoid Arthritis Present Clinical, Economic Challenges for All Stakeholders
